BM Casella,
JP Farmer, DN Nesheva… - Journal of Medicinal …, 2023 - ACS Publications
The inhibition of CXC chemokine receptor 2 (CXCR2), a key inflammatory mediator, is a
potential strategy in the treatment of several pulmonary diseases and cancers. The …